Testing AK139 for nasal polyps and chronic sinusitis
Treatments studied
Part of Ear, nose & throat clinical trials.
This study tests a new medicine called AK139 (given as an injection) to reduce nasal polyps and improve breathing. It is for adults with chronic sinusitis and nasal polyps who still have symptoms despite using steroid sprays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have nasal polyps in both nostrils, with a score of at least 5 (your doctor will check).
- You have ongoing nasal blockage and have tried steroid nasal sprays or previous surgeries.
- You have been using a nasal steroid spray (like Flonase) for at least 4 weeks before starting.
- You have not had sinus surgery in the past 6 months and do not have certain other sinus conditions (like allergic fungal sinusitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injection called LP-003 that may help reduce nasal polyps and improve breathing. It's for people whose symptoms are not controlled by standard treatments like steroid sprays or surgery.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
This study is testing whether certain markers in your blood can predict how well biologic injections (medicines that reduce inflammation) will work for chronic sinusitis with nasal polyps. You'll continue your regular nasal spray and may receive a biologic or a placebo (a shot with no medicine) to see if it improves your symptoms.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.